Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 43.54% |
| 2 | Technology | 19.7% |
| 3 | Financials | 7.47% |
| 4 | Consumer Discretionary | 6.7% |
| 5 | Communication Services | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4476
Seer Inc
SEER
$125M
| $111K | ﹤0.01% |
60,717
+52,982
| +685% | +$108K |
2022 Q1
15 quarters
|
|
4477
CALL
Schrodinger
SDGR
$2.27B
| $111K | ﹤0.01% |
6,200
| – | – |
2025 Q1
3 quarters
|
|
|
DFDV
4478
DeFi Development Corp
DFDV
$171M
| $111K | ﹤0.01% |
21,911
+14,422
| +193% | +$132K |
2025 Q3
1 quarter
|
|
4479
Seres Therapeutics
MCRB
$29.5M
| $111K | ﹤0.01% |
7,432
+6,024
| +428% | +$105K |
2025 Q3
1 quarter
|
|
4480
Freedom Holding
FRHC
$11B
| $110K | ﹤0.01% |
904
+775
| +601% | +$112K |
2023 Q2
10 quarters
|
|
4481
PrimeEnergy Resources
PNRG
$324M
| $109K | ﹤0.01% |
637
+161
| +34% | +$25.9K |
2023 Q2
10 quarters
|
|
4482
Sera Prognostics
SERA
$82.4M
| $108K | ﹤0.01% |
36,722
+26,726
| +267% | +$86.2K |
2024 Q2
6 quarters
|
|
|
CANG
4483
Cango Inc
CANG
$110M
| $108K | ﹤0.01% |
7,212
+3,606
| +100% | +$98.8K |
2025 Q1
3 quarters
|
|
4484
Innovator US Equity Ultra Buffer ETF June
UJUN
$188M
| $108K | ﹤0.01% |
2,888
-25
| -0.9% | -$924 |
2024 Q3
5 quarters
|
|
4485
TransAlta
TAC
$3.91B
| $108K | ﹤0.01% |
8,519
-264,266
| -97% | -$3.95M |
2022 Q2
14 quarters
|
|
4486
FT Vest US Equity Moderate Buffer ETF February
GFEB
$383M
| $107K | ﹤0.01% |
2,574
-2,384
| -48% | -$97.6K |
2024 Q3
5 quarters
|
|
|
SI
4487
Shoulder Innovations Inc
SI
$396M
| $107K | ﹤0.01% |
7,457
+722
| +11% | +$9.84K |
2025 Q3
1 quarter
|
|
4488
Direxion Daily FTSE China Bull 3X ETF
YINN
$526M
| $106K | ﹤0.01% |
2,500
-4,869
| -66% | -$231K |
2023 Q1
11 quarters
|
|
4489
Gaia
GAIA
$35.3M
| $106K | ﹤0.01% |
29,198
+1,406
| +5% | +$6.43K |
2024 Q4
4 quarters
|
|
4490
PUT
Illumina
ILMN
$41.2B
| $105K | ﹤0.01% |
800
| – | – |
2025 Q1
3 quarters
|
|
4491
Karooooo
KARO
$1.85B
| $104K | ﹤0.01% |
2,296
-3,670
| -62% | -$172K |
2022 Q1
15 quarters
|
|
4492
Atomera
ATOM
$184M
| $104K | ﹤0.01% |
47,051
+5,220
| +12% | +$15.8K |
2024 Q4
4 quarters
|
|
|
HVII
4493
DELISTED
Hennessy Capital Investment Corp VII
HVII
| $104K | ﹤0.01% |
+10,000
| New | +$104K |
2025 Q4
0 quarters
|
|
4494
Universal Electronics
UEIC
$73.1M
| $103K | ﹤0.01% |
28,608
| – | – |
2016 Q1
39 quarters
|
|
|
QIPT
4495
DELISTED
Quipt Home Medical
QIPT
| $103K | ﹤0.01% |
29,166
| – | – |
2023 Q1
11 quarters
|
|
|
OBE
4496
Obsidian Energy
OBE
$694M
| $102K | ﹤0.01% |
16,700
-726
| -4% | -$4.39K |
2022 Q1
15 quarters
|
|
|
LFT
4497
Lument Finance Trust
LFT
$26.4M
| $102K | ﹤0.01% |
7,234
+759
| +12% | +$12.1K |
2024 Q3
5 quarters
|
|
|
LGCY
4498
Legacy Education Inc
LGCY
$123M
| $102K | ﹤0.01% |
9,965
+8,189
| +461% | +$78.8K |
2024 Q4
4 quarters
|
|
4499
Vanguard Real Estate ETF
VNQ
$35.4B
| $101K | ﹤0.01% |
1,143
-2,467
| -68% | -$222K |
2022 Q2
14 quarters
|
|
4500
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$278M
| $101K | ﹤0.01% |
2,806
-251
| -8% | -$12.6K |
2022 Q1
15 quarters
|
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $23.5B in Q4 2025, closing 641 positions and reducing 1,714 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 44% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.